|
PIAS4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.121350E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.159400E-01 |
| Normal-vs-Stage2 |
4.706600E-01 |
| Normal-vs-Stage3 |
4.812100E-02 |
| Normal-vs-Stage4 |
3.914100E-02 |
| Stage1-vs-Stage2 |
7.757600E-01 |
| Stage1-vs-Stage3 |
2.439400E-01 |
| Stage1-vs-Stage4 |
2.237600E-01 |
| Stage2-vs-Stage3 |
3.029400E-01 |
| Stage2-vs-Stage4 |
2.444800E-01 |
| Stage3-vs-Stage4 |
7.622800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.729700E-02 |
| Normal-vs-AfricanAmerican |
5.972400E-01 |
| Normal-vs-Asian |
2.794800E-01 |
| Caucasian-vs-AfricanAmerican |
7.987800E-02 |
| Caucasian-vs-Asian |
8.501200E-01 |
| AfricanAmerican-vs-Asian |
1.945630E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.859900E-02 |
| Normal-vs-Female |
1.921620E-01 |
| Male-vs-Female |
1.664180E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.554200E-01 |
| Normal-vs-Age(41-60Yrs) |
9.328400E-02 |
| Normal-vs-Age(61-80Yrs) |
2.583800E-02 |
| Normal-vs-Age(81-100Yrs) |
1.817030E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.889210E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.377700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.674200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.186200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.360000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.867600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.856200E-02 |
| Classical-VS-Follicular |
1.111240E-01 |
| Classical-VS-Other |
7.954400E-01 |
| Classical-VS-Normal |
3.201400E-01 |
| Tall-VS-Follicular |
5.040400E-01 |
| Tall-VS-Other |
4.590400E-01 |
| Tall-VS-Normal |
1.419520E-02 |
| Follicular-VS-Other |
7.721400E-01 |
| Follicular-VS-Normal |
4.203500E-02 |
| Other-VS-Normal |
5.053000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.977580E-01 |
| Normal-vs-N1 |
1.711720E-02 |
| N0-vs-N1 |
1.372630E-01 |
|
|
